IBDEI167 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19553,1,3,0)
 ;;=3^Sarcoid Meningitis
 ;;^UTILITY(U,$J,358.3,19553,1,4,0)
 ;;=4^D86.81
 ;;^UTILITY(U,$J,358.3,19553,2)
 ;;=^5002446
 ;;^UTILITY(U,$J,358.3,19554,0)
 ;;=D86.82^^94^926^50
 ;;^UTILITY(U,$J,358.3,19554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19554,1,3,0)
 ;;=3^Sarcoidosis,Multiple Cranial Nerve Palsies
 ;;^UTILITY(U,$J,358.3,19554,1,4,0)
 ;;=4^D86.82
 ;;^UTILITY(U,$J,358.3,19554,2)
 ;;=^5002447
 ;;^UTILITY(U,$J,358.3,19555,0)
 ;;=D86.84^^94^926^44
 ;;^UTILITY(U,$J,358.3,19555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19555,1,3,0)
 ;;=3^Sarcoid Pyelonephritis
 ;;^UTILITY(U,$J,358.3,19555,1,4,0)
 ;;=4^D86.84
 ;;^UTILITY(U,$J,358.3,19555,2)
 ;;=^5002449
 ;;^UTILITY(U,$J,358.3,19556,0)
 ;;=D86.85^^94^926^42
 ;;^UTILITY(U,$J,358.3,19556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19556,1,3,0)
 ;;=3^Sarcoid Myocarditis
 ;;^UTILITY(U,$J,358.3,19556,1,4,0)
 ;;=4^D86.85
 ;;^UTILITY(U,$J,358.3,19556,2)
 ;;=^5002450
 ;;^UTILITY(U,$J,358.3,19557,0)
 ;;=D86.83^^94^926^40
 ;;^UTILITY(U,$J,358.3,19557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19557,1,3,0)
 ;;=3^Sarcoid Iridocyclitis
 ;;^UTILITY(U,$J,358.3,19557,1,4,0)
 ;;=4^D86.83
 ;;^UTILITY(U,$J,358.3,19557,2)
 ;;=^5002448
 ;;^UTILITY(U,$J,358.3,19558,0)
 ;;=D84.1^^94^926^16
 ;;^UTILITY(U,$J,358.3,19558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19558,1,3,0)
 ;;=3^Defects in Complement System
 ;;^UTILITY(U,$J,358.3,19558,1,4,0)
 ;;=4^D84.1
 ;;^UTILITY(U,$J,358.3,19558,2)
 ;;=^5002439
 ;;^UTILITY(U,$J,358.3,19559,0)
 ;;=D81.810^^94^926^5
 ;;^UTILITY(U,$J,358.3,19559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19559,1,3,0)
 ;;=3^Biotinidase Deficiency
 ;;^UTILITY(U,$J,358.3,19559,1,4,0)
 ;;=4^D81.810
 ;;^UTILITY(U,$J,358.3,19559,2)
 ;;=^5002422
 ;;^UTILITY(U,$J,358.3,19560,0)
 ;;=E88.01^^94^926^2
 ;;^UTILITY(U,$J,358.3,19560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19560,1,3,0)
 ;;=3^Apha-1 Antitrypsin Deficiency
 ;;^UTILITY(U,$J,358.3,19560,1,4,0)
 ;;=4^E88.01
 ;;^UTILITY(U,$J,358.3,19560,2)
 ;;=^331442
 ;;^UTILITY(U,$J,358.3,19561,0)
 ;;=J09.X1^^94^926^25
 ;;^UTILITY(U,$J,358.3,19561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19561,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
 ;;^UTILITY(U,$J,358.3,19561,1,4,0)
 ;;=4^J09.X1
 ;;^UTILITY(U,$J,358.3,19561,2)
 ;;=^5008144
 ;;^UTILITY(U,$J,358.3,19562,0)
 ;;=J09.X2^^94^926^26
 ;;^UTILITY(U,$J,358.3,19562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19562,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
 ;;^UTILITY(U,$J,358.3,19562,1,4,0)
 ;;=4^J09.X2
 ;;^UTILITY(U,$J,358.3,19562,2)
 ;;=^5008145
 ;;^UTILITY(U,$J,358.3,19563,0)
 ;;=J09.X3^^94^926^27
 ;;^UTILITY(U,$J,358.3,19563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19563,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
 ;;^UTILITY(U,$J,358.3,19563,1,4,0)
 ;;=4^J09.X3
 ;;^UTILITY(U,$J,358.3,19563,2)
 ;;=^5008146
 ;;^UTILITY(U,$J,358.3,19564,0)
 ;;=J09.X9^^94^926^28
 ;;^UTILITY(U,$J,358.3,19564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19564,1,3,0)
 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
 ;;^UTILITY(U,$J,358.3,19564,1,4,0)
 ;;=4^J09.X9
 ;;^UTILITY(U,$J,358.3,19564,2)
 ;;=^5008147
 ;;^UTILITY(U,$J,358.3,19565,0)
 ;;=J44.9^^94^926^14
 ;;^UTILITY(U,$J,358.3,19565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19565,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,19565,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,19565,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,19566,0)
 ;;=J44.1^^94^926^12
 ;;^UTILITY(U,$J,358.3,19566,1,0)
 ;;=^358.31IA^4^2
